In our animal studies, we unraveled the synergistic effect of nanobombig and PD‐L1 mAb treatment, reflected by a significant decrease in tumor volume compared with that in the PBS control and PD‐L1 mAb alone. The gene discussed is CD274; the disease is neoplasm.